SECTRA (SECT) Q1 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 24/25 earnings summary
22 Jan, 2026Executive summary
Achieved a strong first quarter with record sales and operating profit, driven by robust growth in recurring and cloud revenues, despite Q1 typically being a seasonally weak period.
All operating areas contributed positively, with Imaging IT Solutions and Secure Communications showing strong growth.
Transition to a cloud-based, as-a-service model is progressing, with significant investments impacting short-term profits but expected to benefit long-term growth and revenue stability.
Customer satisfaction and loyalty remain high, supported by incentive programs and industry-leading rankings.
Financial highlights
Net sales increased by 24% year-over-year to SEK 724 million in Q1; recurring revenue up 21.4% to SEK 482.3 million.
Cloud recurring revenue increased 42% to SEK 122.8 million; recurring revenue accounted for 67% of total revenue.
Operating profit rose 44% to SEK 100 million, with an operating margin of 13.8%.
Profit per share grew to SEK 0.42; profit for the period was SEK 80.4 million, up 30.5%.
Cash flow from operations was negative SEK -57 million, but improved year-on-year; cash balance at period end was SEK 699 million.
Outlook and guidance
Continued heavy investments in cloud transition and service sales expected to impact short-term profits but support long-term growth.
Recurring revenue growth will gradually reduce seasonal fluctuations and support long-term stability.
Major deliveries to healthcare providers are planned over the next few years.
Latest events from SECTRA
- Cloud recurring revenue surged 58% and operating profit rose 21%, led by Imaging IT growth.SECT
Q3 25/266 Mar 2026 - Cloud recurring revenue surged 55.9% and operating profit rose 13.6% year-over-year.SECT
Q4 23/2431 Jan 2026 - Record order intake and recurring revenue growth offset by lower profit during cloud transition.SECT
Q2 24/2511 Jan 2026 - Sales up 13%, cloud recurring revenue up 44%, and profit boosted by a patent settlement.SECT
Q3 24/2521 Dec 2025 - Cloud and recurring revenue growth drive profit, but upfront costs pressure margins.SECT
Q2 25/2612 Dec 2025 - SaaS, AI, and integrated diagnostics drive global growth and leadership in medical IT.SECT
CMD 20251 Dec 2025 - Record order intake and recurring revenue growth drive profitability and cash flow.SECT
Q4 24/2511 Nov 2025 - Order bookings and recurring revenue surged, driven by SaaS and US/Canada growth.SECT
Q1 25/264 Sep 2025